Literature DB >> 20880586

Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease.

Giovanni D'Arena1, Luca Laurenti, Maria Marta Minervini, Silvia Deaglio, Lisa Bonello, Laura De Martino, Laura De Padua, Lucia Savino, Michela Tarnani, Vincenzo De Feo, Nicola Cascavilla.   

Abstract

Regulatory T-cells (Treg) actively maintain immunological self-tolerance and play a significant role in the progression of cancer. Treg cell numbers have been evaluated in 80 patients with previously untreated chronic lymphocytic leukemia (CLL) and in 40 normal healthy volunteers. Treg cells are higher in CLL patients than in controls and correlate with disease status (more advanced clinical stage, peripheral blood B-cell lymphocytosis, absolute CD38+ B-cell number, and more elevated LDH levels). No correlation was found with ZAP-70 expression, IgVH mutational status and cytogenetic abnormalities. This data shows that Treg cell number is abnormal in CLL patients.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20880586     DOI: 10.1016/j.leukres.2010.08.010

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  52 in total

1.  HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism.

Authors:  Roberta Rizzo; Valentina Audrito; Paola Vacca; Davide Rossi; Davide Brusa; Marina Stignani; Daria Bortolotti; Giovanni D'Arena; Marta Coscia; Luca Laurenti; Francesco Forconi; Gianluca Gaidano; Maria Cristina Mingari; Lorenzo Moretta; Fabio Malavasi; Silvia Deaglio
Journal:  Haematologica       Date:  2013-12-20       Impact factor: 9.941

2.  PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia.

Authors:  Bola S Hanna; Philipp M Roessner; Annika Scheffold; Billy M C Jebaraj; Yasmin Demerdash; Selcen Öztürk; Peter Lichter; Stephan Stilgenbauer; Martina Seiffert
Journal:  Leukemia       Date:  2018-12-20       Impact factor: 11.528

3.  Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

Authors:  Paolo Giannoni; Gabriella Pietra; Giorgia Travaini; Rodolfo Quarto; Genti Shyti; Roberto Benelli; Laura Ottaggio; Maria Cristina Mingari; Simona Zupo; Giovanna Cutrona; Ivana Pierri; Enrico Balleari; Alessandra Pattarozzi; Marco Calvaruso; Claudio Tripodo; Manlio Ferrarini; Daniela de Totero
Journal:  Haematologica       Date:  2014-02-21       Impact factor: 9.941

Review 4.  Targeted therapy for chronic lymphocytic leukemia: current status and future directions.

Authors:  Jon E Arnason; Jennifer R Brown
Journal:  Drugs       Date:  2015-02       Impact factor: 9.546

5.  Regulatory T-cells in chronic lymphocytic leukemia: actor or innocent bystander?

Authors:  Giovanni D'Arena; Vittorio Simeon; Fiorella D'Auria; Teodora Statuto; Paola Di Sanzo; Laura De Martino; Aurelio Marandino; Michele Sangiorgio; Pellegrino Musto; Vincenzo De Feo
Journal:  Am J Blood Res       Date:  2013-01-17

6.  Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells.

Authors:  K P Piper; M Karanth; A McLarnon; E Kalk; N Khan; J Murray; G Pratt; P A H Moss
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

7.  MDSCs: the final frontier of the microenvironment in CLL?

Authors:  Katja Zirlik
Journal:  Blood       Date:  2014-07-31       Impact factor: 22.113

8.  Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic Leukemia.

Authors:  Priyanka Banerjee; Ronghua Zhang; Cristina Ivan; Giovanni Galletti; Karen Clise-Dwyer; Federica Barbaglio; Lydia Scarfò; Miguel Aracil; Christian Klein; William Wierda; William Plunkett; Federico Caligaris-Cappio; Varsha Gandhi; Michael J Keating; Maria Teresa S Bertilaccio
Journal:  Cancer Immunol Res       Date:  2019-09-17       Impact factor: 11.151

Review 9.  Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia.

Authors:  Noelia Purroy; Catherine J Wu
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

Review 10.  The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.

Authors:  Danny N Khalil; Eric L Smith; Renier J Brentjens; Jedd D Wolchok
Journal:  Nat Rev Clin Oncol       Date:  2016-03-15       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.